Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Anamorelin structure

Anamorelin

Growth Hormone
Phase 3 Research
70%
Low-Moderate Risk
2/5

Warnings

Not FDA approved
Monitor glucose levels
QT prolongation risk

Contraindications

PregnancyBreastfeedingSevere Hepatic Impairment

Drug Interactions

CYP3A4 InhibitorsCYP3A4 Inducers

Possible Side Effects

Peripheral EdemaIncreased Blood GlucoseQTc ProlongationConstipation

Legal & Regulatory

FDA Status Not FDA Approved
WADA Status Prohibited in Sport
Approved In Japan
Prescription Required

Pregnancy

Category X - Contraindicated